Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Revenue (2016 - 2025)

CV Sciences' Revenue history spans 13 years, with the latest figure at $3.3 million for Q3 2025.

  • For Q3 2025, Revenue fell 15.76% year-over-year to $3.3 million; the TTM value through Sep 2025 reached $14.4 million, down 8.04%, while the annual FY2024 figure was $15.7 million, 1.87% down from the prior year.
  • Revenue for Q3 2025 was $3.3 million at CV Sciences, down from $3.6 million in the prior quarter.
  • Across five years, Revenue topped out at $5.1 million in Q2 2021 and bottomed at $3.3 million in Q3 2025.
  • The 5-year median for Revenue is $4.0 million (2023), against an average of $4.1 million.
  • The largest annual shift saw Revenue crashed 41.43% in 2021 before it rose 9.01% in 2023.
  • A 5-year view of Revenue shows it stood at $5.0 million in 2021, then fell by 22.14% to $3.9 million in 2022, then decreased by 1.76% to $3.8 million in 2023, then increased by 2.18% to $3.9 million in 2024, then dropped by 16.17% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Revenue are $3.3 million (Q3 2025), $3.6 million (Q2 2025), and $3.6 million (Q1 2025).